| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +21% |
| 3Y CAGR | +6% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +60% |
| 3Y CAGR | +5% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹5,017.60 +119.10 (2.43%) | 22,413.87 | 30.49 | 5.33 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,906.50 -40.00 (0.50%) | 19,865.00 | 105.93 | 22.76 | ||
₹1,351.70 -38.60 (2.78%) | 19,309.50 | 29 | 4.95 | |||
Alivus Life SciencesALIVUS | ₹1,361.00 -32.60 (2.34%) | 17,081.19 | 28.32 | 5.13 |